These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Sumatriptan in migraine and cluster headache]. Ferrari MD Ned Tijdschr Geneeskd; 1991 Aug; 135(35):1573-5. PubMed ID: 1656279 [No Abstract] [Full Text] [Related]
4. Rationale for the use of 5-HT1-like agonists in the treatment of migraine. Feniuk W; Humphrey PP; Perren MJ; Connor HE; Whalley ET J Neurol; 1991; 238 Suppl 1():S57-61. PubMed ID: 1646289 [TBL] [Abstract][Full Text] [Related]
5. Sumatriptan in acute migraine: pharmacology and review of world experience. Peroutka SJ Headache; 1990; 30 Suppl 2():554-60. PubMed ID: 2177047 [TBL] [Abstract][Full Text] [Related]
6. SUMATRIPTAN: a receptor-targeted treatment for migraine. Moskowitz MA; Cutrer FM Annu Rev Med; 1993; 44():145-54. PubMed ID: 8386498 [TBL] [Abstract][Full Text] [Related]
8. Treatment of migraine attacks with sumatriptan. Subcutaneous Sumatriptan International Study Group N Engl J Med; 1991 Aug; 325(5):316-21. PubMed ID: 1647495 [TBL] [Abstract][Full Text] [Related]
9. Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache. Dechant KL; Clissold SP Drugs; 1992 May; 43(5):776-98. PubMed ID: 1379152 [TBL] [Abstract][Full Text] [Related]
10. [Sumatriptan and its use in treatment of migraine and cluster headaches]. PrusiĆski A Neurol Neurochir Pol; 1992; Suppl 2():28-48. PubMed ID: 1337766 [TBL] [Abstract][Full Text] [Related]
11. Sumatriptan: efficacy and contribution to migraine mechanisms. Pearce JM J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1103-5. PubMed ID: 1336041 [No Abstract] [Full Text] [Related]
12. Treatment of acute cluster headache with sumatriptan. Sumatriptan Cluster Headache Study Group N Engl J Med; 1991 Aug; 325(5):322-6. PubMed ID: 1647496 [TBL] [Abstract][Full Text] [Related]
13. From serotonin receptor classification to the antimigraine drug sumatriptan. Saxena PR; Ferrari MD Cephalalgia; 1992 Aug; 12(4):187-96. PubMed ID: 1326401 [TBL] [Abstract][Full Text] [Related]
14. Possible benefit of GR43175, a novel 5-HT1-like receptor agonist, for the acute treatment of severe migraine. Doenicke A; Brand J; Perrin VL Lancet; 1988 Jun; 1(8598):1309-11. PubMed ID: 2897560 [TBL] [Abstract][Full Text] [Related]
15. Serotonin receptor subtypes and neuropsychiatric diseases: focus on 5-HT1D and 5-HT3 receptor agents. Peroutka SJ Pharmacol Rev; 1991 Dec; 43(4):579-86. PubMed ID: 1663621 [No Abstract] [Full Text] [Related]
16. Sumatriptan is a potent vasoconstrictor of human dural arteries via a 5-HT1-like receptor. Jansen I; Edvinsson L; Mortensen A; Olesen J Cephalalgia; 1992 Aug; 12(4):202-5. PubMed ID: 1326402 [TBL] [Abstract][Full Text] [Related]
17. Sumatriptan for migraine. Med Lett Drugs Ther; 1992 Oct; 34(880):91-3. PubMed ID: 1326077 [No Abstract] [Full Text] [Related]
18. Methodology of clinical trials of sumatriptan in migraine and cluster headache. Pilgrim AJ Eur Neurol; 1991; 31(5):295-9. PubMed ID: 1653136 [TBL] [Abstract][Full Text] [Related]
19. Expression of mRNA for the serotonin 5-hydroxytryptamine1D beta receptor subtype in human and bovine cerebral arteries. Hamel E; Fan E; Linville D; Ting V; Villemure JG; Chia LS Mol Pharmacol; 1993 Aug; 44(2):242-6. PubMed ID: 8394988 [TBL] [Abstract][Full Text] [Related]
20. The selectivity of MDL 74,721 in models of neurogenic versus vascular components of migraine. Petty MA; Elands J; Johnson MP; Linnik MD; Hamel E; Moskowitz MA; Lee WS; McCarty DR; Hibert M; Baron BM Eur J Pharmacol; 1997 Oct; 336(2-3):127-36. PubMed ID: 9384224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]